Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79,643,662
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
40,843,175
-
Shares change
-
+2,389,286
-
Total reported value, excl. options
-
$110,685,079
-
Value change
-
+$5,557,133
-
Put/Call ratio
-
62%
-
Number of buys
-
48
-
Number of sells
-
41
-
Price
-
$2.71
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q2 2025
As of 30 Jun 2025 Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,843,175 shares of stock of the company.
Largest 10 holders included BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock, Inc., First Light Asset Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Woodline Partners LP, GEODE CAPITAL MANAGEMENT, LLC, Blue Owl Capital Holdings LP, and Ensign Peak Advisors, Inc.
This table shows 85 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.